Osteoarthritis, Hip Clinical Trial
Official title:
Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem
NCT number | NCT02288117 |
Other study ID # | 1202 HP |
Secondary ID | |
Status | Active, not recruiting |
Phase | |
First received | |
Last updated | |
Start date | July 2015 |
Est. completion date | May 2023 |
Verified date | December 2020 |
Source | Waldemar Link GmbH & Co. KG |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The objective of this PMCF is to collect clinical and radiographic outcome information on Total Hip Arthroplasty (THA) performed with LINK® SP-CL® Hip Prosthesis Stem under routine conditions. The results collected will be used to clinically confirm the performance and safety of the LINK® SP-CL® Hip Prosthesis Stem in terms of the manufacturer's obligation to perform a PMCF. Furthermore the results can be used for future regulatory processes if needed.
Status | Active, not recruiting |
Enrollment | 240 |
Est. completion date | May 2023 |
Est. primary completion date | May 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Skeletally mature - Subject agrees to comply with the required postoperative management and follow-up evaluations - Undergone at least six (6) month of unsuccessful, conservative, non-surgical treatment - Patient understands the conditions of the study and is willing and able to comply with the postoperative scheduled clinical and radiographic evaluations and the prescribed postoperative management. - Patient signed Informed Consent. Exclusion Criteria: - Body Mass Index (BMI) > 40 kg/m2 - Poor general state of health - Acute and chronic infections, local and systemic - Pharmaceutical or other drug abuse, alcoholism - Allergies to implant materials - Distinctive muscular, nerve, vascular or other diseases which put the affected limb at risk - Insufficient / inadequate bone mass- or quality which prevents a stable anchorage of the prosthesis - Severe osteoporosis - Foreseeable overload/ overstressing of the joint prosthesis - Acetabular defects - Female patient who is pregnant or plans to became pregnant during the course of the study - Prisoner - Patient who, as judged by the surgeon, is mentally incompetent or is unlikely to be compliant with the prescribed postoperative routine and follow-up evaluation schedule - Patient who has not signed the Informed Consent |
Country | Name | City | State |
---|---|---|---|
Germany | HELIOS ENDO-Klinik | Hamburg | |
Germany | Krankenhaus Barmherzige Brüder Regensburg | Regensburg | Bayern |
Italy | L'Istituto Ortopedico Gaetano Pini | Milan | |
Spain | Hospital Sant Rafael | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Waldemar Link GmbH & Co. KG |
Germany, Italy, Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stem Survival Rate | The survival of the stem | Up to 5 years | |
Secondary | Complication Rate | Number and kind of complications | Up to 5 years | |
Secondary | Reoperation Rate | number of reoperations | Up to 5 years | |
Secondary | Harris Hip Score (HHS) | Clinical Score to get information about the subjects pain and hip function, collected continuously | Up to 5 years | |
Secondary | Oxford Hip Score (OHS) | PROM to assess function and pain after THR | Up to 5 years | |
Secondary | Forgotten Joint Score (FJS) | awareness of the artificial joint | Up to 2 years | |
Secondary | Mid Thigh Pain | Pain occuring in the front and mid part of the femur | Up to 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05773261 -
Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups
|
N/A | |
Recruiting |
NCT05223777 -
KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)
|
N/A | |
Recruiting |
NCT04731077 -
Avenir Complete Post-Market Clinical Follow-Up Study
|
N/A | |
Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Not yet recruiting |
NCT06162195 -
The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
|
N/A | |
Withdrawn |
NCT02743208 -
Evaluation of a Short Femoral Stem in Total Hip Arthroplasty
|
N/A | |
Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
Active, not recruiting |
NCT02229279 -
Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures
|
N/A | |
Active, not recruiting |
NCT02851992 -
A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem
|
N/A | |
Completed |
NCT01618708 -
A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip
|
N/A | |
Completed |
NCT01700933 -
Dose-response: Exercise Therapy on Hip Osteoarthritis
|
N/A | |
Completed |
NCT01214954 -
Early Rehabilitation After Total Hip Replacement
|
N/A | |
Active, not recruiting |
NCT00294424 -
Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements
|
N/A | |
Terminated |
NCT00588861 -
Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement
|
N/A | |
Withdrawn |
NCT05054595 -
Audio-Recorded vs. Nurse-Led Brief Mindfulness-Based Intervention
|
N/A | |
Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
Recruiting |
NCT05014113 -
H-28 DELTA ST-C and Minima Retrospective Study.
|
||
Completed |
NCT01066936 -
Mini Stem DEXA (Dual Energy X-ray Absorptiometry)
|
||
Recruiting |
NCT05530551 -
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
|
N/A |